← Leaderboards
Milos D Ikonomovic
University Of Pittsburgh At Pittsburgh
$11,868,106
Attributed
$13,093,489
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,639,320 · 11
VA$0 · 3
By mechanism
P01$27,605,322 · 8
R01$4,502,269 · 2
U24$1,531,729 · 1
I01$0 · 3
Top collaborators
- Matthew M. Harper6 shared
- C Edward Dixon5 shared
- Howard J Aizenstein3 shared
- Ann D. Cohen3 shared
- Victor Luis Villemagne3 shared
- Tamer S Ibrahim1 shared
- Julia K Kofler1 shared
- Joseph Mettenburg1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- William E Klunk$26,129,826
- Tony E Godfrey$9,226,279
- Rena A. S. Robinson$7,952,589
- Victor Luis Villemagne$6,217,884
- Ann D. Cohen$26,999,530
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainPathologyImageSynapsesAmyloidNeuropathologyAmyloid Beta-ProteinTau ProteinsDensityCognitionDementiaCognitiveImpaired CognitionMeasurementPreventBiochemicalPositron-Emission TomographyNerve DegenerationAutopsyBlood VesselsAreaAging
Grant awards (49)
Multimodal in Vivo and Postmortem Analysis of ARIA-Relevant Pathophysiology$1,531,729
U24 · FY2025 · NS
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,703,737
P01 · FY2024 · AG
Neuropathological correlates of the SMBT-1 PET ligand for imaging astrogliosis in Alzheimer's disease$629,485
P01 · FY2024 · AG · contact PI
Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment$386,789
P01 · FY2024 · AG · contact PI
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,932,984
P01 · FY2023 · AG
Neuropathological correlates of the SMBT-1 PET ligand for imaging astrogliosis in Alzheimer's disease$599,535
P01 · FY2023 · AG · contact PI
Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment$376,523
P01 · FY2023 · AG · contact PI
The role of astrogliosis in aging and the pathological and clinical progression of Alzheimer's Disease$6,909,110
P01 · FY2022 · AG
Neuropathological correlates of the SMBT-1 PET ligand for imaging astrogliosis in Alzheimer's disease$656,836
P01 · FY2022 · AG · contact PI
Targeting Cerebrovascular Dysfunction for White Matter Protection$391,250
R01 · FY2022 · NS · contact PI
Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment$376,223
P01 · FY2022 · AG · contact PI
Targeting Cerebrovascular Dysfunction for White Matter Protection$391,250
R01 · FY2021 · NS · contact PI
Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment$375,323
P01 · FY2021 · AG · contact PI
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy$696,340
R01 · FY2020 · AG · contact PI
Targeting Cerebrovascular Dysfunction for White Matter Protection$391,250
R01 · FY2020 · NS · contact PI
Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment$375,705
P01 · FY2020 · AG · contact PI
Neuropathological Validation of Tau and Amyloid-beta PET Imagingand Correlations with Synapses and Vascular Pathology$360,061
P01 · FY2020 · AG · contact PI
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI$0
I01 · FY2020 · VA · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2020 · VA · contact PI
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy$707,295
R01 · FY2019 · AG · contact PI
Neuropathological Validation of Tau and Amyloid-beta PET Imagingand Correlations with Synapses and Vascular Pathology$344,741
P01 · FY2019 · AG · contact PI
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI$0
I01 · FY2019 · VA · contact PI
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy$642,740
R01 · FY2018 · AG · contact PI
Neuropathological Validation of Tau and Amyloid-beta PET Imagingand Correlations with Synapses and Vascular Pathology$295,879
P01 · FY2018 · AG · contact PI
Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment$288,168
P01 · FY2018 · AG · contact PI
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI$0
I01 · FY2018 · VA · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2018 · VA · contact PI
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy$649,335
R01 · FY2017 · AG · contact PI
Neuropathological Validation of Tau and Amyloid-beta PET Imagingand Correlations with Synapses and Vascular Pathology$295,004
P01 · FY2017 · AG · contact PI
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI$0
I01 · FY2017 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2017 · VA · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2017 · VA · contact PI
Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy$632,809
R01 · FY2016 · AG · contact PI
Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment$352,139
P01 · FY2016 · AG · contact PI
Neuropathological Validation of Tau and Amyloid-beta PET Imagingand Correlations with Synapses and Vascular Pathology$294,801
P01 · FY2016 · AG · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2016 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2016 · VA · contact PI
Multifunctional rehabilitative therapy to reduce Alzheimer pathology after TBI$0
I01 · FY2016 · VA · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2016 · VA · contact PI
Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment$279,006
P01 · FY2015 · AG · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2015 · VA · contact PI
Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment$314,372
P01 · FY2014 · AG · contact PI
Synaptic, Cholinergic and Amyloid Alterations in Mild Cognitive Impairment$140,835
P01 · FY2014 · AG · contact PI
Chronic effects of blast injury: analyses of Alzheimer related pathology$0
I01 · FY2014 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2014 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2014 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2014 · VA · contact PI
Memantine Therapy for Improved Functional Recovery After TBI$0
I01 · FY2011 · VA · contact PI
Quantitative Neuropathological Correlates of In Vivo PiB Retention$318,066
P01 · FY2010 · AG · contact PI